The areas under the ROC curve (AUC) of the prognostic model showed that HMGA1 and FOXM1 had moderate discrimination performance in lung adenocarcinoma patients with 1- and 3-year OS (overall survival), and poor discrimination in 5-year OS. Here, HMGA1 is linked to lung adenocarcinoma.